1. Home
  2. GOSS vs MGYR Comparison

GOSS vs MGYR Comparison

Compare GOSS & MGYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$0.39

Market Cap

104.7M

Sector

Health Care

ML Signal

HOLD

Logo Magyar Bancorp Inc.

MGYR

Magyar Bancorp Inc.

N/A

Current Price

$17.75

Market Cap

114.1M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
GOSS
MGYR
Founded
2015
1922
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Savings Institutions
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
104.7M
114.1M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
GOSS
MGYR
Price
$0.39
$17.75
Analyst Decision
Buy
Analyst Count
8
0
Target Price
$4.19
N/A
AVG Volume (30 Days)
8.7M
3.0K
Earning Date
05-14-2026
05-04-2026
Dividend Yield
N/A
2.25%
EPS Growth
N/A
26.83
EPS
N/A
0.50
Revenue
$48,471,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$201.64
N/A
P/E Ratio
N/A
$35.50
Revenue Growth
N/A
N/A
52 Week Low
$0.32
$13.77
52 Week High
$3.87
$20.00

Technical Indicators

Market Signals
Indicator
GOSS
MGYR
Relative Strength Index (RSI) 37.36 53.31
Support Level $0.33 $17.00
Resistance Level $0.47 $17.93
Average True Range (ATR) 0.04 0.42
MACD 0.04 0.03
Stochastic Oscillator 46.72 76.19

Price Performance

Historical Comparison
GOSS
MGYR

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).

About MGYR Magyar Bancorp Inc.

Magyar Bancorp Inc is an independent, community financial services provider offering traditional banking services to individual, business, and government customers. The Company attracts retail deposits through its main office in New Brunswick, New Jersey, and branch offices in Middlesex and Somerset Counties, and invests those funds mainly in commercial and residential real estate loans, commercial business loans, SBA loans, home equity loans and lines of credit, construction and land loans, and investment securities. Revenues are derived mainly from interest on loans and securities and from fees and service charges, with lending relationships focused on small to mid-sized businesses and individual consumers in central and northern New Jersey.

Share on Social Networks: